1. Douglas Hanahan, et al. The Hallmarks of Cancer. Cell, 2000. 100: p. 57–70.2. Hanahan, D., et al. Hallmarks of Cancer: The Next Generation. Cell, 2011. 144(5): p. 646-674.3. Vernieri, C., et al. Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions. Cancer Discovery,2016. 6(12): p. 1315-1333.4. Haoyang Li, et al. CaMeRe: A Novel Tool for Inference of Cancer Metabolic Reprogramming. Front Oncol. 2020Feb 25;10:207.5. Liem Minh Phan, et al. Cancer metabolic reprogramming: importance, main features, and potentials for precisetargeted anti-cancer therapies. Cancer Biol Med. 2014 Mar; 11(1): 1-19.6. Tengjiao Fan, et al. Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of AerobicGlycolysis: Implications in Tumor Treatment. Cancers (Basel). 2019 Mar; 11(3):317.7. Anne Le, et al.Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumorprogression. Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2037-42.8. Kareenhalli V. Venkatesh, et al. Encyclopedia of Systems Biology.. In: Dubitzky W., Wolkenhauer O., Cho KH.,Yokota H. (eds) Encyclopedia of Systems Biology. Springer, New York, NY. 2013.9. Bhaskar Bhattacharya, et al. The Warburg Effect and Drug Resistance. Br J Pharmacol. 2016 Mar;173(6):970-9.10. Nuno Santos, et al. Lactate as a Regulator of Cancer Inflammation and Immunity. Immunometabolism.2019;1:e190015.11. Grant M. Fischer, et al. Metabolic Strategies of Melanoma Cells: Mechanisms, Interactions With the Tumor Microenvironment, and Therapeutic Implications. Pigment Cell Melanoma Res. 2018Jan; 31(1): 11–30.12. Kathleen A Vermeersch, et al. Applications of Metabolomics in Cancer Researchtt. J Carcinog. 2013 Jun18;12:9.13. Chi V Dang, et al. Therapeutic targeting of cancer cell metabolism. J Mol Med (Berl). 2011 Mar;89(3):205-12.